About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Adherence in Adolescents and Children Treated on Quetiapine

NCT00680888·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

7–17

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

At least one psychotic symptom (delusions or hallucinations) before age 18.
Start of treatment in a maximum period of 2 years after the onset of first psychotic symptom
Written informed consent by parents or guardians and patients.

You may not be if

Pregnancy or lactancy
High risk of aggression or suicidal behaviour
Alcohol dependence

The record

StatusCompleted

PhaseNo phase

Taking part30

StartedAug 2005

UpdatedDec 9, 2010

Conditions

Clareo Health | Adherence in Adolescents and Children Treated on Quetiapine